Test Price
650 AED✅ Home Collection Available
Pneumocystis IFA Test in UAE | 650 AED | DHA Guidelines
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing and Direct IFA methodology.
- Specimen Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
- Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Pneumocystis IFA test detects Pneumocystis jirovecii organisms in respiratory specimens using direct immunofluorescence, delivering rapid same-day results critical for immunocompromised patients. This assay is a cornerstone in diagnosing Pneumocystis pneumonia (PCP) with high sensitivity and specificity.
| Our Direct IFA Test | Closest Alternative (GMS Stain / PCR) |
|---|---|
| 99.9% Diagnostic Sensitivity (ISO-validated) | GMS: ~80% sensitivity; PCR: >95% (but 24-48h TAT) |
| Direct Immunofluorescence – morphological confirmation | GMS: labor-intensive; PCR: molecular, requires specialized lab |
| Same-day report (sample by 9 AM) | GMS: 2–3 days; PCR: 24–48 hours |
Physician Insight & Safety Protocols
“As a general practitioner with extensive clinical experience, I emphasize that early recognition of Pneumocystis pneumonia symptoms—such as persistent dry cough, fever, and progressive dyspnea—is critical in immunocompromised patients. The IFA test provides rapid, definitive diagnosis, enabling timely specialist referral and treatment initiation. If you or a loved one experiences these symptoms, seek medical evaluation without delay.”
— Dr. Ajay Singh, DHA License No. 36234132, General Practitioner
Clinical Advisory & Safety Precautions
Medication Warning
Do not discontinue prescribed medication (e.g., prophylactic antibiotics, immunosuppressants) without consulting your supervising physician. Abrupt cessation may worsen underlying conditions or predispose to acute infection.
Exclusion Criteria & Red Flag Symptoms
- Severe respiratory distress (SpO₂ < 90% on room air) requiring urgent emergency care or ICU admission.
- Inability to expectorate sputum and contraindication for bronchoscopy (e.g., bleeding diathesis).
- Red Flag Symptoms requiring immediate ER: sudden cyanosis, air hunger, hemoptysis, or sharp pleuritic chest pain.
Patient FAQ & Clinical Guidance
1. What is a Pneumocystis IFA test, and why is it recommended?
This direct immunofluorescence assay detects Pneumocystis jirovecii organisms in sputum or bronchoalveolar lavage fluid, confirming Pneumocystis pneumonia diagnosis rapidly. It allows clinicians to visualize cyst forms of the fungus under a microscope, providing same-day results critical for starting targeted antimicrobial therapy in immunocompromised patients.
2. How is the sample collected, and what are the preparation instructions?
Sputum induction may be performed with hypertonic saline under medical supervision, or bronchoalveolar lavage collected during bronchoscopy. The specimen must be placed in a sterile screw-capped container and transported under cold chain (2–8°C) to the lab within 4 hours. No special patient preparation is required, but avoid mouthwash or eating immediately prior to collection to reduce contamination. This procedure is conducted exclusively within an accredited hospital facility.
3. What does a positive result mean, and what are the next steps?
A positive result indicates active Pneumocystis jirovecii infection requiring immediate anti-PCP therapy under specialist care. Your doctor will typically initiate high-dose trimethoprim-sulfamethoxazole and may order further tests such as LDH or chest CT. Treatment response is monitored clinically; always complete the full prescription course even if symptoms improve.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance: All patient data is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
ISO Accreditation: Certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | Pneumocystis IFA Test |
| Price (AED) | 650 AED |
| Turnaround Time | Same-day report (sample by 9 AM) |
| Sample Type / Matrix | Induced sputum or bronchoalveolar lavage (BAL) – Hospital Extraction Only |
| Methodology Used | Direct Immunofluorescence Assay (IFA) |
| ICD-10-CM Code | B59 |
| LOINC Code | 3173-2 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians